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Abstract:  71 
Addiction is a maladaptive pattern of behavior following repeated use of reinforcing drugs in 72 
predisposed individuals, and leading to lifelong changes. A common substrate of these changes lies 73 
in alterations of neurons releasing dopamine in the ventral and dorsal territories of the striatum. The 74 
serotonin 5-HT2B receptor has been involved in various behaviors including impulsivity, response to 75 
antidepressants and to psychostimulants pointing toward putative interactions with the dopamine 76 
system. Despite these findings, it remains unknown whether 5-HT2B receptors directly modulate 77 
dopaminergic activity and the possible mechanisms involved. To answer these questions, we 78 
investigated the contribution of 5-HT2B receptors to cocaine-dependent behavioral responses. Male 79 
mice permanently lacking 5-HT2B receptors, even restricted to dopamine neurons, developed 80 
heightened cocaine-induced locomotor responses. Retrograde tracing combined with single cell 81 
mRNA amplification indicated that 5-HT2B receptors are expressed by mesolimbic dopamine 82 
neurons. In-vivo and ex-vivo electrophysiological recordings showed that 5-HT2B-receptor 83 
inactivation in dopamine neurons affects their neuronal activity and increases AMPA- over NMDA-84 
mediated excitatory synaptic currents. These changes are associated with lower ventral striatum 85 
dopamine activity and blunted cocaine self-administration. These data identify the 5-HT2B receptor 86 
as a pharmacological intermediate and provide mechanistic insight into attenuated dopamine tone 87 
following exposure to drugs of abuse. 88 
 89 
 90 
Significance Statement 91 
Here we report that mice lacking 5-HT2B receptors totally or exclusively in dopamine neurons exhibit 92 
heightened cocaine-induced locomotor responses. In spite of the sensitized state of these mice, we 93 
found that associated changes include lower ventral striatum dopamine activity, and lower cocaine 94 
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operant self-administration. We described the selective expression of 5-HT2B receptors in 95 
subpopulation of dopamine neurons sending axons to ventral striatum. An increased bursting in-vivo 96 
properties of these dopamine neurons and a concomitant increase in AMPA synaptic transmission to 97 
ex-vivo dopamine neurons was found in mice lacking 5-HT2B receptors. These data support that the 98 
chronic 5-HT2B-receptor inhibition makes mice behaving as animals already exposed to cocaine with 99 
higher cocaine-induced locomotion associated with changes in DA neuron reactivity. 100 
 101 
 102 
Introduction  103 
Serotonin (5-hydroxytryptamine, 5-HT) system is implicated in the establishment of drug use-104 
associated behaviors via various receptors [For review see (Müller and Homberg, 2015)]. A common 105 
substrate of addictive behaviors lies in neurons releasing DA in the mesocorticolimbic system, as 106 
demonstrated via elegant and diverse investigations in both animals and humans (Hyman et al., 107 
2006). This system comprises midbrain projections from the ventral tegmental area (VTA) and 108 
substantia nigra to cortical territories and subcortical limbic areas including the dorsal striatum and 109 
nucleus accumbens (NAcc). DA neurons can be regulated through 5-HT receptors expressed in VTA 110 
and NAcc (Hayes and Greenshaw, 2011). Both of these regions receive 5-HT projections from the 111 
dorsal raphe nucleus, which thereby can regulate DA neurotransmission (Di Giovanni et al., 2010). 112 
Cocaine binds with high affinity to the dopamine (DA), norepinephrine, and 5-HT transporters, 113 
blocks reuptake of these monoamines and increases their extracellular concentrations in the brain. 5-114 
HT has also been shown to modulate cocaine action both in clinical and preclinical studies (Filip et 115 
al., 2010).  116 
 The 5-HT2 receptors have been implicated as likely candidates for mediating the influence of 117 
5-HT in cocaine abuse (De Deurwaerdere and Spampinato, 1999) as well as to traits (e.g., 118 
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impulsivity) that contribute to the development of cocaine use disorder and relapse in humans [for 119 
review see (Howell and Cunningham, 2015)]. The role of 5-HT2B receptors in cocaine addiction 120 
remains poorly understood. Recent pharmacological studies have shown that the injection of 5-HT2B-121 
receptor antagonists in rats had no effect on cocaine-induced DA outflow in the NAcc shell or core, 122 
or in the dorsal striatum (Devroye et al., 2015). In addition, the same group showed that 5-HT2B-123 
receptor antagonist treatment significantly reduced basal DA levels in the NAcc shell (Devroye et al., 124 
2015), were devoid of effect in the dorsal striatum, and increased DA levels in the prefrontal cortex 125 
(PFC) (Devroye et al., 2016). They also showed that the preferential 5-HT1A-receptor antagonist, 126 
WAY 100635, blocks the changes in PFC and NAcc basal DA levels induced by 5-HT2B-receptor 127 
antagonists, supporting interplay between PFC 5-HT1A and 5-HT2B receptors (Devroye et al., 2017). 128 
Despite these findings, it remained unclear whether the 5-HT2B receptor modulates at long term 129 
DA/reward system and the mechanisms involved.  130 
 Here, we report that mice with permanent genetic ablation even restricted to DA neurons, or 131 
long-term pharmacologic blockade (chronic antagonist treatment) of 5-HT2B receptors exhibit 132 
heightened cocaine-induced locomotor responses. Associated changes include lower ventral striatum 133 
DA activity, and lower cocaine operant self-administration. Furthermore, a lack of this receptor 134 
increases the cocaine reactivity of VTA DA neurons projecting to the NAcc shell and the ratio of 135 
AMPA- over NMDA-mediated excitatory postsynaptic currents in these neurons. These data support 136 
that the 5-HT2B receptor expressed by DA neurons is an intermediate in drug-evoked plasticity.  137 
  138 
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Materials and methods 139 
Reagents.  140 
Cocaine, SKF 81297 [ (±)-6-chloro-7,8-dihydroxy-1-phenyl- 2,3,4,5-tetrahydro-1H-3-benzazepine 141 
hydrobromide] (Sigma-Aldrich, Saint-Quentin Fallavier, France), SB206553 [3,5-Dihydro-5-methyl-142 
N-3-pyridinylbenzo[1,2-b:4,5-b']dipyrrole-1(2H)-carboxamide], RS127445 [2-amino-4- (4-143 
fluoronaphth-1-yl)-6-isopropylpyrimidine] and quinpirole hydrochloride (Tocris Bioscience, USA) 144 
were slowly dissolved in 0.9% (wt/vol) NaCl solution (saline). All drugs were administered 145 
intraperitoneally (ip) (0.1 ml/10 g body weight). RS127445 was found to have sub-nanomolar 146 
affinity for the 5-HT2B receptor (pKi = 9.5±0.1) and at least 1,000 fold selectivity for this receptor as 147 
compared to numerous other receptors and monoamine uptake sites (Diaz et al., 2012). Based on 148 
initial studies showing that RS127445 completely (at 1, 0.5, and 0.1 mg/kg; ip) or partially (at 0.05 149 
mg/kg) blocked MDMA-induced locomotion in mice and had no effect on basal locomotor activity 150 
(Doly et al., 2008; Doly et al., 2009; Banas et al., 2011; Diaz et al., 2012), we used 1 (data not 151 
shown) or 0.5 mg/kg dose (ip) for the acute injection. Injections were administered 30 minutes 152 
before the test session in acute studies. Htr2b+/+ mice chronically treated with RS127445 153 
continuously received the 5-HT2B antagonist at 1 mg/kg/day or vehicle (10 mM DMSO) via 154 
subcutaneous (sc) osmotic pumps (Alzet® model 2004) for 4 weeks.  155 
 156 
Animal studies 157 
Animals. Htr2b-/- mice (MGI:1888735) used in these experiments were maintained in a 129S2/SvPas 158 
(129S2) background. Wild type 129S2 mice (8-10 week old) used as a control group were derived 159 
from heterozygote crosses and were bred at our animal facility. Swiss-Webster mice carrying drd2-160 
EGFP bacterial artificial chromosome transgenes were generated by the Gene Expression Nervous 161 
System Atlas program at Rockefeller University (MGI:3843608) (Gong et al., 2003). Initial 162 
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experiments evaluating the cocaine responses were performed independently on small groups of 163 
males and females. Since no statistical difference was found between genders, later groups were 164 
composed of males for other experiments. All mice were maintained on a 12h light: 12h dark 165 
schedule (lights on at 8:00), and housed in groups of 3-5 of the same genetic background and sex 166 
after weaning. Mice were moved to experimental room in their home cage at least 5 days prior to 167 
testing to allow for habituation to the environment and stayed there until the end of experiments. 168 
Behavioral studies were carried out in the afternoon (14:00–20:00). The observer was blind to 169 
experimental conditions being measured. Behavioral tests and animal care were conducted in 170 
accordance with standard ethical guidelines (National Institutes of Health’s ‘Guide for the Care and 171 
Use of Laboratory animals’, and European Directive 2010/63/ UE) and were approved by the local 172 
Ethic Committee for Animal Experiments (No. 01170.02). 173 
 174 
Experimental design and statistical analysis 175 
The total number of animals per group was defined according to the standard deviation and the 176 
difference score observed for each small group in a pilot experiment. Mice were randomly assigned 177 
to different experimental groups of 4 to 6 animals and independent experiments were performed at 178 
least 3 times. Normal distributions and homoscedasticity were verified by Shapiro-Wilk’s test and 179 
Levene’s test, respectively. Putative outliers were determined by the ROUT method. The statistical 180 
analysis was developed with the software Infostat and GrapPad Prism 6. Microdialysis and 181 
locomotor activity data were analyzed by two-way ANOVA repeated measures (RM) with gene or 182 
drug treatment and time as factors. Food and cocaine self-administration was analyzed by three-way 183 
ANOVA with hole, day and genotype as factors. Behavioral and biochemical assays were analyzed 184 
by two-way analysis of variance (ANOVA) with treatment and genotype as main factors. One-way 185 
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ANOVA or t-test and Bonferroni test were used for post-hoc comparisons depending on the 186 
experiment. P<0.05 was predetermined as the threshold for statistical significance.  187 
 188 
Generation of Htr2b floxed mice. Genomic contigs of Htr2b encompassing exon 1 and 2 and 189 
ﬂanking sequence were obtained by screening of a 129S2 mouse genomic library. For the gene 190 
targeting construct, a 10 kb BamHI-XhoI fragment containing the two first exons was selected, while 191 
a 4 kb SacI-SacI fragment containing exon 2, which includes the ATG start codon and 5' UTR was 192 
used to induce the targeted deletion. A LoxP site was inserted in the 5'-UTR and a neomycine-193 
resistance (NEO) cassette ﬂanked by two LoxP sites in the ClaI site of the second intron. Then, the 194 
SacI-SacI fragment comprising the floxed construct was excised and electroporated into 129S2 195 
embryonic stem (ES) cells which were subjected to G418 selection. Targeted homologous 196 
recombination was conﬁrmed by PCR and Southern blot analysis. A positive ES clone was injected 197 
into C57Bl/6NCrl blastocysts and implanted into pseudopregnant mice. A chimeric male displaying 198 
germ-line transmission was then used to propagate the ﬂoxed Htr2b (Htr2bfl/fl) allele on a 199 
C57Bl/6NCrl background for the two first generations. More than ten backcrosses of Htr2bfl/fl mice 200 
with 129S2 (Htr2b+/+) mice were performed. Htr2bfl/fl alleles were detected by PCR using the 201 
oligonucleotide F1: CTAACATTTTTCATCCACATCTA as forward primer located in the 5' UTR 202 
(position of the primers are indicated in Figure). Paired to this primer, the reverse primer R1: 203 
TCCCTCGAAGCTTATCGGCGCG, located in the 5' end of the second intron led to the 204 
ampliﬁcation of a 1 kbp product in the presence of the Htr2bfl/fl allele, while the reverse primer R2: 205 
ACTTTAATTGGGACTCGCTGAT, located in the 3' side of the ClaI site permits ampliﬁcation of a 206 
309 bp amplicon indicative of the Htr2b null allele.  207 
 208 
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DA neurons selective ablation of Htr2b.  Adults Htr2bfl/fl mice were exclusively inactivated in 209 
DA neurons for Htr2b by crossing with DAT-Cre+/0 (BAC–Slc6-icre) mice (Turiault et al., 2007). 210 
Htr2bfl/fl;DAT-Cre+/0 (Htr2bDAKO) were generated on a mixed 129S2.B6 background used as F3 on 211 
129S2 strain with littermate Htr2bfl/fl;DAT-Cre0/0 (Htr2bfl/fl) as control mice. Identification of DA 212 
neurons was performed in DAT-Cre+/0;Gt(ROSA)26Sortm1.1(CAG-EGFP)Fsh (DAT-Cre+/0;RCE or Dat-213 
GFP) mice, who expressed EGFP only after recombination [Jackson Lab, also named RCE:loxP 214 
mice harbor the R26R CAG-boosted EGFP (RCE) reporter allele with a loxP-flanked STOP cassette 215 
upstream of the enhanced green fluorescent protein (EGFP) gene-MGI:4412373]. 216 
 217 
Locomotor activity. Locomotor activity was measured in an actimeter (circular corridor with four 218 
infrared beams placed at every 90° Imetronic, France) as described (Doly et al., 2009). Counts were 219 
incremented by consecutive interruption of two adjacent beams (i.e., mice moving through one-220 
quarter of the corridor). Mice were individually placed in the activity box for 30 min followed by an 221 
ip injection of a saline solution and recorded for another 60 min during 3 days consecutively for 222 
habituation before all locomotor experiments. The day of experiment, mice were injected with a 223 
saline solution or 5-HT2B antagonists (RS127445, 0.5 mg/kg or SB206553, 3 mg/kg) and 224 
individually placed in the activity box for 30 min before being ip injected with a saline or cocaine 225 
(7.5 to 20 mg/kg) solution and the locomotor activity was recorded for two hours. 226 
 227 
Locomotor sensitization. For locomotor sensitization in this study, we used a two-injection protocol 228 
shown to be as efficient as repeated injections protocol but involving much less mice handling, thus 229 
minimizing stress and contextual habituation that can be confounding factors (Valjent et al., 2010). 230 
After 30 min in the actimeter, mice received a first injection of cocaine (7.5, 15 or 20 mg/kg) and the 231 
locomotor activity was recorded for two hours. Mice were then challenged seven days later with a 232 
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second injection of cocaine at the same concentration as the first injection, same injection protocol, 233 
and the locomotor activity was recorded for two hours. 234 
 235 
Microdialysis in freely moving mice. The microdialysis experiment was performed using awake 236 
mice as described (Doly et al., 2009). Initially, anesthetized animals were placed in a stereotaxic 237 
frame (D. Kopf, Tujunga, CA, USA) and a stainless-steel guide cannula (CMA/12, CMA 238 
Microdialysis, North Chelmsford, MA, USA; outer diameter 0.7 mm) was implanted in the NAcc. 239 
The cannula was then secured to the skull with dental cement, and the skin was sutured. Animals 240 
were kept in individual cages for a seven-day recovery. Dialysis probes were equipped with a 241 
Cuprophan membrane (membrane length 1 mm and diameter 0.24 mm, cutoff: 5,000 Da, 242 
Microdialysis AB, Sweden). According to Praxinos and Franklin (2001), stereotaxic coordinates in 243 
mm were for NAcc AP +1.2, ML +0.6, DV -4.2 both to bregma and dura surface, respectively. After 244 
insertion, probes were perfused at a constant rate of 1μl/min with artificial CSF containing 154.1 245 
mM Cl-, 147 mM Na+, 2.7 mM K+, 1 mM Mg2+, and 1.2 mM Ca2+, adjusted to pH 7.4 with 2 mM 246 
sodium phosphate buffer. The microdialysis experiment was performed using awake mice. 247 
Dialysates were collected every 20 min. All measurements were carried out 150 min after the 248 
beginning of perfusion, by which time a steady state was achieved. Mice were injected with cocaine 249 
(20 mg/kg; ip) 20 minutes after the beginning of measurements. At the end of the experiment, all 250 
brains were fixed in a 4% formaldehyde solution and serial coronal slices were made on a 251 
microtome. Histological examination of cannula tip placement was subsequently made on 100 μm 252 
safranine-stained coronal sections. Dialysate samples were injected without any purification into an 253 
HPLC system that consists of a pump linked to an automatic injector (Agilent 1100, Palo Alto, CA, 254 
USA), a reverse-phase column (Zorbax SB C18, 3.5 lm, 150·4.6 mm; Agilent Technologies, Palo 255 
Alto, CA, USA) and a coulometric detector (Coulochem III; ESA Inc., Chelmsford, USA) with a 256 
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5011 analytical cell to quantify DA or 5-HT. The first electrode was fixed at -100 mV and the second 257 
electrode at +300 mV. The gain of the detector was set at 50 nA. The signal of the second electrode 258 
was connected to an HP Chemstation for HPLC. The composition of the mobile phase was 50 mM 259 
NaH2PO4, 0.1 mM Na2EDTA, 0.65 mM octyl sodium sulphate and 14% (v⁄v) methanol, pH 3.5. The 260 
flow rate was set at 1 ml⁄min. The quantity of neurotransmitters calculated based on standard injected 261 
in each HPLC run in the same range of concentrations as experimental samples. 262 
 263 
Tissue preparation and immunofluorescence. Ten minutes after cocaine or saline injection, and 264 
locomotor recording, mice were rapidly anesthetized with pentobarbital (500 mg/kg, ip; Sanofi-265 
Aventis) and perfused transcardially with 4% (w/v) paraformaldehyde in 0.1 M sodium phosphate 266 
buffer, pH 7.5 (Bertran-Gonzalez et al., 2008). Brains were postfixed overnight in the same solution 267 
and stored at 4°C. Thirty-μm-thick sections were cut with a Vibratome (Leica) and stored at –20°C in 268 
a solution containing 30% (v/v) ethylene glycol, 30% (v/v) glycerol, and 0.1 M sodium phosphate 269 
buffer, until they were processed for immunofluorescence. Free-floating sections were rinsed in Tris-270 
buffered saline (TBS) (0.10 M Tris, 0.14 M NaCl), pH 7.4, incubated for 5 min in TBS containing 271 
3% H2O2 (v/v) and 10% methanol (v/v), and rinsed three times 10 min in TBS. After 20 min 272 
incubation in 0.2% Triton X-100 in TBS (v/v), sections were rinsed three times in TBS, blocked with 273 
30 g/L BSA in TBS, and incubated overnight (or longer as indicated) at 4°C with the primary 274 
antibodies. Antibody for TH is a mouse monoclonal (1:750 with an incubation ≥ 2 d; Sigma-Aldrich) 275 
and for pERK using rabbit polyclonal antibodies against diphospho-Thr-202/ Tyr-204-ERK1/2 276 
(1:400; Cell Signaling Technology). After incubation with primary antibody, sections were rinsed 277 
three times for 10 min in TBS and incubated for 45 min with chicken Cy3-coupled (1:400; The 278 
Jackson Laboratory) or goat Alexa Fluor 488-coupled (1:400; Invitrogen) secondary antibodies. 279 
Finally, sections were rinsed for 10 min twice in TBS and twice in Tris buffer (0.25 M Tris, pH 7.4) 280 
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before mounting in Vectashield (Vector Laboratories). Brain regions were identified using a mouse 281 
brain atlas and sections equivalent to 1.54 mm from Bregma were taken. Sections were processed as 282 
previously described (Doly et al., 2008). Confocal microscopy and image analysis were performed at 283 
the Institut du Fer à Moulin Imaging Facility. Labeled images from each region of interest were 284 
obtained bilaterally using sequential laser-scanning confocal microscopy (SP2; SP5 Leica). Neuronal 285 
quantification was performed in 375 x 375 μm images by counting nuclear/cytoplasm Cy3 286 
immunofluorescence (for pERK1/2). Cell counts were performed by an observer unaware of the 287 
treatment received by the mice.  288 
 289 
Food and cocaine self-administration. Prior to cocaine self-administration testing, mice were 290 
individually housed and food deprived to 85-90% of their free-feeding body weight, and then trained 291 
to respond for food pellets in mouse operant chambers (Med Associates Inc. Georgia, VT, USA) 292 
equipped with two nose-pokes, one randomly selected as the active and the other as the inactive 293 
nose-poke. A cue light located above the active nose-poke was paired contingently with the delivery 294 
of the reinforcer. Animals were first trained to respond for food pellets (Testdiet, Richmond, IN, 295 
USA) in one-hour daily self-administration sessions on a fixed ratio 1 (FR1) schedule of 296 
reinforcement until responding for food criteria was acquired (a minimum of 20 reinforcers, more 297 
than 75% of correct responding, and stabilization for 2 to 3 days) (see Fig. 8a for time scale of these 298 
experiments). After this initial training, mice were kept in ad libitum conditions in order to recover 299 
their body weight before proceeding with the catheter implantation as previously described (Soria et 300 
al., 2005). Mice were anesthetized with a mixture of ketamine/xylazine (5:1; 0.10 ml/10 g, ip) and 301 
implanted with indwelling intravenous silastic catheters on their right jugular vein as previously 302 
described (Soria et al., 2005). After surgery, animals were allowed to recover for 3 days before 303 
initiation of self-administration sessions. Saline solution self-administration sessions were performed 304 
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until obtaining a low and stable responding pattern in order to prevent any food-seeking or food-305 
extinction disturbance in succeeding cocaine self-administration. Mice were then trained to self-306 
administer cocaine at the dose of 0.250 mg/kg/infusion during 8 days on a FR1 schedule of 307 
reinforcement, with a stability criteria set at a minimum of 5 cocaine infusions and 75% responding 308 
on the active nose-poke during 3 days. Following stable responding, all mice underwent dose-309 
response experiments, where cocaine was presented at the doses of 0.125, and 0.500 mg/kg/infusion 310 
during 4 consecutive days respectively. Subsequently, a progressive ratio procedure was performed 311 
in order to test the motivation of the mice to work for cocaine at the dose of 0.125 mg/kg/infusion, 312 
where the response requirements to earn an infusion escalated according to the following series: 1-2-313 
3-5-12-18-27-40-60-90-135-200-300-450-675-1000. The patency of intravenous catheters was 314 
evaluated at the end of the experiments by an infusion of 0.05 ml of thiopental sodium (5 mg/ml) 315 
(Braun Medical) through the catheter. If prominent signs of anesthesia were not apparent within 3 316 
seconds of the infusion the mouse was removed from the experiment. 317 
 318 
Sucrose preference. Sucrose preference was evaluated in the two-bottle choice test in individually 319 
caged Htr2b+/+ and Htr2b-/- mice. In the first phase, two bottles of water were available during two 320 
consecutive days. Then, the liquid from one of the bottles was replaced with a 2% sucrose solution, 321 
and made available during 3 days. Total liquid intake, as well as, sucrose preference was determined 322 
by weighing the bottles once every morning. 323 
 324 
Single-cell RT-PCR. Swiss-Webster mice carrying Drd2-EGFP bacterial artificial chromosome 325 
transgenes were generated by the Gene Expression Nervous System Atlas program at Rockefeller 326 
University (New York). For single-cell RT-PCR experiments, 1-2 week-old Drd2-EGFP mice were 327 
used to direct EGFP protein expression to D2 receptor expressing neurons. Mice were anesthetized 328 
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and decapitated, and the brain was rapidly dissected out. Horizontal slices (250-μm thick) were 329 
prepared using a vibratome, in artificial cerebral spinal fluid aCSF supplemented with sucrose. After 330 
a 1-h recovery period, individual slices were placed in an electrophysiology chamber continuously 331 
perfused with aCSF bubbled with Carbogen and maintain at 22 °C. Neurons were visualized using an 332 
Olympus BX51WI upright microscope holding x5 and x40 objectives, a fluorescent lamp, and 333 
infrared, red, and green fluorescence filters. The methodology involving harvesting of cytoplasmic 334 
content and subsequent single cell PCR amplification has been described elsewhere (Cauli et al., 335 
1997). Briefly, borosilicate glass pipettes (3-5 MΩ) were made in a HEKA PIP5 puller and filled 336 
with 8 μl of autoclaved RT-PCR internal solution (in mM): 144 K-gluconate; 3 MgCl2; 0.5 EGTA; 337 
10 HEPES, pH 7.2 (285/295 mOsm). Single DA neurons in the VTA and SNc were approached with 338 
a pipette and after a whole-cell connection was established, cytoplasmic content of the cell was 339 
harvested by applying gentle negative pressure to the pipette. Cell content was expelled into a tube 340 
where a reverse transcription (RT) reaction was performed in a final volume of 10 μl. Target cDNA 341 
sequences were thereafter amplified by conducting a multiplex nested PCR, designed to 342 
simultaneously detect the enzyme tyrosine hydroxylase (TH), D2 receptor and 5-HT2B receptors. The 343 
following primers used were: TH, external sense CTGGCCTTCCGTGTGTTTCAGTG, external 344 
anti-sense CCGGCTGGTAGGTTTGATCTTGG, internal sense 345 
AGTGCACACAGTACATCCGTCAT and internal anti-sense GCTGGTAGGTTTGATCTTGGTA; 346 
D2 receptor external sense GCAGCCGAGCTTTCAGAGCC, external anti-sense 347 
CCTGCGGCTCATCGTCTTAAG, internal sense AGAGCCAACCTGAAGACACCAC and 348 
internal anti-sense CTTAAGGGAGGTCCGGGTTTTG; 5-HT2B external sense 349 
CACTGGAGAAAAGGCTGCAGTA, external anti-sense TTGCACTGATTGGCCTGAATTG, 350 
internal sense GGCTATATGGCCCCTCCCAC and internal anti-sense 351 
GGTCCAGGGAAATGGCACAG. 352 
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Initially, all three genes were simultaneously amplified in a single tube using 10 μl of cDNA, 200 353 
nM of each primer and 2.5 U of Taq polymerase in a final volume of 100 μl. The PCR reaction was 354 
carried out using a 6-min hot start at 94°C, followed by a 21-cycle program (94°C for 30 s, 60°C for 355 
30 s and 72°C for 30 sec). Subsequently, 2 μl of the amplified cDNA was used as the template for 356 
the second amplification step. Here, each gene was individually amplified in a separate tube, and a 357 
35-cycles program using the same cycling conditions as mentioned above, in a final volume of 100 358 
μl. The products of the second PCR were analyzed by electrophoresis in 2.5% agarose gels using 359 
ethidium bromide. The sizes of the PCR-generated fragments were as predicted by the mRNA 360 
sequences and were further verified by direct sequencing of the final products. 361 
 362 
In-vivo electrophysiology: extracellular single-cell recordings. Mice were anesthetized with 363 
chloral hydrate, 400 mg/kg ip, supplemented as required to maintain optimal anesthesia throughout 364 
the experiment, and were positioned in a stereotaxic frame (David Kopf). Body temperature was kept 365 
at 37 °C by means of a thermostatically controlled heating blanket. Procedures for DA cell 366 
electrophysiological recording were described previously (Mameli-Engvall et al., 2006). An incision 367 
was made in the midline to expose the skull. A burr hole was drilled above the VTA (coordinates: 368 
between 3.5 ± 0.3 mm posterior to bregma and 0.5 ± 0.3 mm lateral to midline (Paxinos and 369 
Franklin, 2001). Recording electrodes were pulled with a Narishige electrode puller from borosilicate 370 
glass capillaries with outer and inner diameters of 1.50 and 1.17 mm, respectively (Harvard 371 
Apparatus Ltd.). The tips were broken under microscope control and ﬁlled with 1.5% Neurobiotine 372 
in 0.5% Na-acetate. These electrodes had tip diameters of 1–2 mm and impedances of 4–8 MΩ. They 373 
were lowered through the burr hole with a micro drive, and a reference electrode was placed in the 374 
subcutaneous tissue. Electrical signals were ampliﬁed by a high-impedance ampliﬁer (Axon 375 
Instruments) and monitored visually with an oscilloscope (Tektronix TDS 2002) and audibly through 376 
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an audio monitor (A.M. Systems Inc.). When a single unit was well isolated, the oscilloscope sweep 377 
was triggered from the rising phase of the action potential and set sufficiently fast to display the 378 
action potential over the entire screen (usually 0.5 ms per unit). Such continuous observation of the 379 
expanded action potential provided assurance that the same single unit was being monitored 380 
throughout the experiment. The unit activity digitized at 25 KHz was stored in Spike2 program 381 
(Cambridge Electronic Design, CED, United Kingdom).  382 
 383 
Firing Pattern Quantification. DA cell firing in-vivo was analyzed with respect to the average 384 
firing rate and the percentage of spikes within a burst (SWB) (the number of SWB divided by total 385 
number of spikes in a given window of 1-min duration; %SWB). DA cell firing in-vivo was analyzed 386 
with respect to the average firing rate and the %SWB. Neuron basal activity was defined on the basis 387 
of at least 5 min or 500 spikes. The electrophysiological characteristics of VTA neurons were 388 
analyzed in the active cells encountered by systematically passing the microelectrode in a 389 
stereotaxically deﬁned block of brain tissue including the VTA. Its margins ranged from 2.92–3.88 390 
mm posterior to bregma, 0.24–0.96 mm mediolateral with respect to the bregma point, and 3.7–4.7 391 
mm ventral to the cortical surface, according to the coordinates of Paxinos and Franklin (2001). 392 
Sampling was initiated on the right side and then on the left side. Each electrode descent was spaced 393 
at least 10 μm from the others.  394 
 395 
DA cell identification. Extracellular identification of DA neurons was based on their location as 396 
well as on the set of unique electrophysiological properties that characterize these cells in-vivo: (i) a 397 
typical triphasic action potential with a marked negative deflection; (ii) a characteristic long-duration 398 
(>2.0 ms) action potential; (iii) an action potential width from start to negative of >1.1 ms; (iv) a 399 
slow firing rate (< 10 Hz) with an irregular single spiking pattern and occasional short, slow bursting 400 
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activity. These electrophysiological properties distinguish DA from non-DA neurons. The mouse 401 
was killed with an overdose of anesthetic. The brain was removed and placed in a 4% 402 
paraformaldehyde solution. Sixty-μm thick VTA sections were cut and stained with Neurobiotin and 403 
Tyrosine Hydroxylase antibody (a mouse monoclonal antibody for TH, 1:500 with an incubation 404 
2>d; Sigma-Aldrich), and the recorded neurons were identified by fluorescence microscopy. We also 405 
added two criteria: (i) that the recording be stable (i.e., the absence of cell perturbation following our 406 
saline solution injection); and (ii) that the recorded cells be more than 4 mm from the surface of the 407 
brain. These parameters have been used classically to identify DA cells (Mameli-Engvall et al., 408 
2006).  409 
 410 
Electrophysiological response to cocaine and quinpirole. The firing rate and %SWB were 411 
evaluated using a 60-s moving window and a 15-s time step. Each cell activity was rescaled by its 412 
baseline value averaged during the 3-min period before 10 μl cocaine (20 mg/kg) or quinpirole (0.25-413 
0.50 mg/kg) in 0.9% NaCl was injected ip. For firing frequency, rescaling was defined using 414 
x*100/xb with xb being the baseline firing frequency. The results are presented as mean ± SEM. The 415 
effect of cocaine or quinpirole was tested by comparing the maximum observed during baseline and 416 
after cocaine injection. For each neuron we determined xav, the maximum of the fluctuations before 417 
cocaine injections (during the 2.5-min period used as baseline); xav = max (x)av − mean (x) av, and 418 
xap is the maximum after cocaine (or quinpirole) injection (during the 3-min period after drug 419 
injection). We used a paired nonparametric Wilcoxon test (Wilcoxon signed rank test) to compare 420 
xav and xap for firing frequency in two populations. 421 
 422 
Electrophysiological recordings from brain slices. AMPA/NMDA ratio of evoked excitatory 423 
postsynaptic currents (EPSCs) from putative DA neurons of VTA were obtained with whole–cell 424 
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voltage–clamp recordings using a CsCl-based internal medium, as described (Glangetas et al., 2015). 425 
Six- to seven-week old Htr2b+/+ control and Htr2b-/- mice were anesthetized (Ketamine/Xylazine) for 426 
slice preparation. Horizontal 250-μm slices were prepared in bubbled ice-cold 95% O2/5% CO2-427 
equilibrated solution containing (in mM): cholineCl 110; glucose 25; NaHCO3 25; ascorbic acid 428 
11.6; Na+-pyruvate 3.1; KCl 2.5; NaH2PO4 1.25; MgCl2 7; CaCl2 0.5, were then heated for 10 429 
minutes in the same medium at 32ºC. Subsequently, slices were stored at room temperature in 95% 430 
O2/5% CO2-equilibrated artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl 124; 431 
NaHCO3 26.2; glucose 11; KCl 2.5; NaH2PO4 1; CaCl2 2.5; MgCl2 1.3. Slices were kept at 32–432 
34°C in a recording chamber and were continuously perfused with 2.5 ml/min ACSF. Whole-cell 433 
voltage-clamp recording techniques were used to measure excitatory synaptic responses of the 434 
ventral tegmental area (VTA). Synaptic currents were evoked by pulses (60 μs) delivered at 0.1Hz 435 
through a glass pipette placed 200 μm rostral to the patched neurons. Recordings were made in the 436 
presence of picrotoxin (100 μM) to block GABAA receptor-mediated currents. Putative DA neurons 437 
were identified as large cells (>30 pF capacitance) in the lateral part of the VTA, which are prone to 438 
project to the nucleus accumbens (Lammel et al., 2008). Currents were amplified, filtered at 5 kHz 439 
and digitized at 20 kHz and recorded at a holding potential of +40 mV (IGOR PRO, Wavemetrics, 440 
USA). Access resistance was monitored by a step of -4 mV (0.1 Hz) and experiments were discarded 441 
if the access resistance increased more than 20%. The internal solution contained (in mM): CsCl 130; 442 
NaCl 4; MgCl2 2; EGTA 1.1; HEPES 5; Na2ATP 2; Na+-creatine-phosphate 5; Na3GTP 0.6, and 443 
spermine 0.1, with a liquid junction potential of –3 mV. AMPA receptor (AMPAR)-EPSCs were 444 
pharmacologically isolated using NMDA receptor (NMDAR) antagonist APV (50 μM), while 445 
NMDAR-EPSCs were then calculated by subsequent digital subtraction. The ratio of 446 
AMPAR/NMDAR responses was calculated by taking the peak values of these averaged (20 sweeps) 447 
currents. All drugs were obtained from Abcam (Cambridge, UK), Tocris (Bristol, UK), and HelloBio 448 
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(Bristol, UK). APV was dissolved in water, whereas picrotoxin was dissolved in DMSO (diluted 449 
1000x in the final volume). Online/offline analysis was performed using IGOR-6 (Wavemetrics, 450 
USA) and Prism (Graphpad, USA). Compiled data are expressed as mean ± SEM  451 
 452 
Immunoblot analysis. Wild type and mutant mice (2-month-old, age-matched) were killed by 453 
decapitation and their brains were immediately dissected out from the skull and frozen on dry ice. 454 
Microdiscs of tissue were punched out from frozen slices (500-μm thick) within the striatum using a 455 
stainless steel cylinder (1.4 mm diameter). Samples were homogenized in 1% SDS, equalized for 456 
their protein content and analyzed by western blot. The antibody dilutions were 1/1000 and 1/500 for 457 
antibodies against Golf and D1 receptor, respectively. Antibody for Golf was from our laboratory 458 
(Corvol et al., 2001) and for D1 receptor was from Luedtke et al. (1999). Antibodies were revealed 459 
by Fluoprobes 682 goat anti-rabbit or mouse IgG (Interchim, Montluçon, France) at a 1:5000 460 
dilution. The fluorescent immunocomplexes were detected with Odyssey (LI-COR Biosciences, 461 
Lincoln, Nebraska). Quantification was carried out by measuring the average intensity in regions of 462 
interest using the Odyssey software and data were analyzed with the Prism 6 software (GraphPad 463 
Software, San Diego, CA). 464 
 465 
Retrograde tracing of VTA or SNc neurons. Drd2-EGFP mice were anesthetized with ketamine 466 
(50 mg/kg) and xylazine (2 mg/kg) and fixed in a stereotaxic apparatus. Stereotaxically guided 467 
injections were made through holes in the dorsal surface of the cranium. Glass capillary tubes were 468 
pulled (HEKA pipette puller PIP5) and tips broken to 40 μm diameter. Capillaries were filled with 469 
Dextran Alexa Fluor 568 (Invitrogen). Pressure injections of tracer (0.1 μl for 10 min) were targeted 470 
to the NAcc (80 nl) or dorsal striatum (200 nl) for VTA or SNc neurons labeling, respectively. 471 
Micropipettes were left in place 10 min before removal to minimize leakage. The stereotaxic 472 
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coordinates used for these injections were obtained from the atlas (Paxinos and Franklin, 2001) 473 
adapted and checked in pilot experiments for P15 mice (NAcc AP +1, ML +0.6, DV -3.5; Dst AP +1, 474 
ML +1.5, DV -2 both to bregma and dura surface, respectively. Correct placement site was verified 475 
by red-dextran injection. After a 10 days survival, the animals were proceed for the single cell PCR 476 
experiment.  477 
 478 
Binding assays. Mice were decapitated and brain regions, including the prefrontal cortex and 479 
striatum, were dissected on ice and homogenized with 25 ml of ice cold buffer containing 50mM 480 
Tris, 5mM MgCl2, pH 7.4. Homogenates were centrifuged for 20 min at 15,000x g. The pellet was 481 
resuspended and centrifuged under the same condition three times. To the final suspension (0.2-0.6 482 
mg/ml) was added for one hour, [3H]raclopride (81.3Ci/mmol; Perkin Elmer; USA) or 483 
[3H]SCH23390 (85.6Ci/mmol; Perkin Elmer; USA) (2 nM) for D2 and D1 receptors binding, 484 
respectively. The process was terminated by immersing the tubes in ice-cold buffer followed by 485 
rapid filtration through Whatman GF/B filters. Radioactivity was measured using liquid scintillation 486 
counting. Binding data were analyzed using the iterative non-linear fitting software GraphPad Prism 487 
6 to estimate dissociation constants (KD) and maximum number of sites (Bmax). 488 
  489 
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Results 490 
Permanent 5-HT2B-receptor gene inactivation increases locomotor effects of cocaine. Locomotor 491 
activity recorded every 5 min was evaluated after an intraperitoneal (ip) injection of cocaine 30 min 492 
after the start of the session. Over the first 10 minutes, cocaine dose-dependently increased 493 
locomotor activity in Htr2b-/- mice significantly more than in Htr2b+/+ mice (Fig. 1a) at every tested 494 
dose (multiple unpaired t-test, 7.5 mg/kg t51 = 2.196, P=0.033; 15 mg/kg t51 = 3.407, P=0.0013; 20 495 
mg/kg t51 = 4.619, P<0.0001). We then evaluated in more details locomotor effects of cocaine 496 
injection at 7.5 and 15 mg/kg. A first injection of cocaine (7.5 mg/kg) induced a stronger increase in 497 
locomotor activity in Htr2b-/- than Htr2b+/+ mice (Fig. 1b, two-way ANOVA RM, significant effect 498 
of genotype F(1, 22) = 6.04, p=0.022 and time F(18, 396) = 23.80, p<0.0001 with interactions F(18, 396) = 499 
2.08, p=0.0061). Bonferroni post-test showed a significant increase at 5, 20, and 25 min. Similar 500 
results were obtained with cocaine 15 mg/kg, (Fig. 1c, significant effect of genotype F(1, 22) = 5.22, 501 
p=0.032 and time F(18, 396) = 23.93, p<0.0001 with interactions F(18, 396) = 3.15, p<0.0001). Bonferroni 502 
post-test showed a significant increase at 5-20 min. Behavioral sensitization can be measured by 503 
enhancement of drug-evoked locomotor responses following repeated drug exposure or injections 504 
performed a week apart (Stewart and Badiani, 1993; Valjent et al., 2010). Following a second 505 
cocaine injection, at the same dose, seven days after the first, Htr2b-/- mice exhibited higher cocaine-506 
induced locomotor response than Htr2b+/+ mice (7.5 mg/kg, Fig. 1b, significant effect of genotype 507 
F(1, 22) = 6.07, p=0.022 and time F(18, 396) = 49.84, p<0.0001 with interactions F(18, 396) = 5.42, 508 
p<0.0001). Bonferroni post-test showed a significant increase at 5-20 min. Similar results were 509 
obtained with cocaine 15 mg/kg, (Fig. 1c significant effect of genotype F(1, 22) = 5.62, p=0.027 and 510 
time F(18, 396) = 17.84, p<0.0001 with interactions F(18, 396) = 3.22, p<0.0001). Bonferroni post-test 511 
showed a significant increase at 5-20 min. The fold increase in cocaine induced-locomotor activity at 512 
the second injection with respect to the first was similar in both genotypes at either 7.5 or 15 mg/kg 513 
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dose (7.5 mg/kg, Fig. 1b, unpaired t-test t22 = 0.528, P=0.60; 15 mg/kg, Fig. 1c unpaired t-test t22 = 514 
0.592, P=0.56). Two-way ANOVA RM analysis of the total locomotor activity over 60 min showed 515 
significant effects of genotype and time of injection (7.5 mg/kg, Fig. 1b, main factors genotype F(1, 516 
22) = 6.44, p=0.019 and injection time F(1, 22) = 7.76, p=0.010, no interactions F(1, 22) = 0.39, p=0.54; 517 
15 mg/kg, Fig. 1c main factors genotype F(1, 22) = 6.02, p=0.022 and injection time F(1, 22) = 9.76, 518 
p=0.005, no interactions F(1, 22) = 2.62, p=0.12). Bonferroni post-test showed that total locomotor 519 
activity over 60 min after a 2nd injection was significantly higher in Htr2b-/- compared to Htr2b+/+ 520 
mice and to the 1st injection. Interestingly, the locomotor activity at the first injection in Htr2b-/- was 521 
similar to that at the second in sensitized Htr2b+/+ mice. 522 
 523 
Permanent pharmacological 5-HT2B-receptor blockade increases locomotor effects of cocaine. 524 
We used ip injection of 5-HT2B receptor antagonists in wild type mice to confirm these effects. A 525 
single ip injection of the highly selective and potent 5-HT2B receptor antagonist, RS127445 (0.5 526 
mg/kg) (Bonhaus et al., 1999), did not modified basal locomotion (Fig. 2a). Similar absence of 527 
differential effects was obtained with the 5-HT2B/2C-receptor antagonist SB206553 (3 mg/kg) (Fig. 528 
2a). Interestingly, we did not observe difference in cocaine-(15 mg/kg) induced locomotion in 529 
Htr2b+/+ mice after a single ip injection of RS127445 (0.5 mg/kg), compared to vehicle treated mice 530 
(Fig. 2a), or of the 5-HT2B/2C receptor antagonist SB206553 (3 mg/kg) (Fig. 2a). We then evaluated 531 
whether the enhanced locomotor response to cocaine in Htr2b-/- mice was developmentally mediated 532 
or due to long-term neuroadaptations following permanent inhibition of the receptor activity in adult 533 
Htr2b+/+ mice. A four-week treatment with RS127445 (1 mg/kg/d) by subcutaneous (sc) release with 534 
mini-osmotic pumps (Launay et al., 2002) in adult mice, did not modified basal locomotion (Fig. 535 
2b). However, a four-week treatment with RS127445 (1 mg/kg/d) significantly enhanced cocaine-536 
(15 mg/kg) induced locomotor response after a first injection (Fig. 2b two-way ANOVA RM, 537 
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significant effect of RS127445 F(1, 14) = 11.61, p=0.0042 and time F(18, 252) = 21.12, p<0.0001 with 538 
interactions F(18, 252) = 1.77, p=0.029) compared to vehicle-treated mice. Bonferroni post-test showed 539 
a significant increase at 15, 20, and 30 min. A second cocaine injection, at the same dose seven days 540 
after the first, increased more the locomotion of chronically RS127445-treated Htr2b+/+ than vehicle-541 
treated Htr2b+/+ mice (Fig. 2b two-way ANOVA RM, significant effect of RS127445 F(1, 14) = 25.19, 542 
p=0.0002 and time F(18, 252) = 78.29, p<0.0001 with interactions F(18, 252) = 8.32, p<0.0001). 543 
Bonferroni post-test showed a significant increase at 5-30 min. The fold increase in cocaine induced-544 
locomotor activity at the second injection with respect to the first was similar (Fig. 2b unpaired t-test 545 
t14 = 0.808, P=0.43). Two-way ANOVA RM analysis of the total locomotor activity over 60 min 546 
showed significant effects of genotype and time of injection (main effects of RS127445 F(1, 14) = 547 
17.43, p=0.0009 and injection time F(1, 14) = 31.59, p<0.0001, no interactions F(1, 14) = 2.26, p=0.155). 548 
Bonferroni post-test showed that total locomotor activity over 60 min after a 2nd injection was 549 
significantly higher in 4 weeks RS127445-treated compared to vehicle-treated Htr2b+/+ mice and to 550 
the first injection. Together these results suggest that permanent inactivation of the 5-HT2B receptor 551 
leads to increased sensitivity to cocaine as measured by locomotor responses, independently of 552 
putative consequences of the receptor knockout during embryonic development. 553 
 554 
The lack of 5-HT2B receptors reduces ventral striatal cocaine-induced DA outflow and ERK1/2 555 
phosphorylation. To further investigate the consequences of the loss of 5-HT2B receptor expression, 556 
we compared monoamine extracellular concentrations after cocaine injection in Htr2b+/+ and Htr2b-/- 557 
mice first measured by microdialysis. In awake Htr2b-/- mice, a dose of cocaine (20 mg/kg), which 558 
increased locomotor activity (Fig. 1a, 3b), elicited a significantly lower increase (2.5-fold) in DA 559 
extracellular levels in the NAcc compared to Htr2b+/+ mice, in which extracellular DA concentration 560 
increased 10-fold (Fig. 3a, two-way ANOVA RM, significant effect of genotype F(1, 13) = 43.29, 561 
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p<0.0001 and time F(6, 78) = 26.00, p<0.0001 with interactions F(6, 78) = 1.77, p<0.0001). Bonferroni 562 
post-test showed that cocaine-dependent DA level was significantly lower in Htr2b-/- compared to 563 
Htr2b+/+ mice at 20-80 min. At the same dose, no difference in extracellular cocaine-dependent 5-HT 564 
accumulation in the NAcc was observed (Fig. 3a). Striatal extracellular signal-regulated kinase 565 
(ERK)1/2 phosphorylation is a marker of DA-dependent D1 receptor stimulation and an essential 566 
component of signaling pathways initiating synaptic plasticity and long-term behavioral effects of 567 
drugs of abuse (Girault et al., 2007). Cocaine injection (20 mg/kg) significantly increased locomotor 568 
activity for the first 10 minutes (Fig. 3b, two-way ANOVA, significant effect of genotype F(1, 10) = 569 
9.23, p<0.0125 and treatment F(1, 10) = 24.02, p=0.0006 with interactions F(1, 10) = 9.06, p=0.013). 570 
Bonferroni post-test showed that total locomotor activity over 10 min was significantly higher in 571 
Htr2b-/- compared to Htr2b+/+ mice and to the vehicle injection. Ten minutes after cocaine injection, 572 
we quantified the number of phosphorylated-ERK1/2 (p-ERK1/2) immunoreactive neurons in 573 
various areas of the striatum of Htr2b+/+ and Htr2b-/- mice (Fig. 3c-e). Activated neurons in vehicle 574 
and cocaine conditions displayed globally an equivalent amount of p-ERK1/2 staining, and 575 
immunoreactive areas of p-ERK1/2 (not illustrated). Two-way ANOVA, showed an significant 576 
effect of genotype F(1, 10) = 40.23, p<0.0001 and treatment F(1, 10) = 234.2, p<0.0001, with interaction 577 
between cocaine treatment and genotype (F(1, 10) = 36.34, p<0.0001) only in NAcc shell (Fig. 3e). 578 
Bonferroni post-test showed that cocaine induced a significantly lower number in p-ERK1/2 579 
immuno-positive neurons in the NAcc shell of Htr2b-/- than Htr2b+/+ mice (4-fold vs. 10-fold). By 580 
contrast, the increase in the number of p-ERK1/2 immuno-positive neurons in NAcc core and dorsal 581 
striatum did not differ between genotypes (Fig. 3e two-way ANOVA, no effect of genotype in core 582 
F(1, 10) = 4.57, p=0.058, or dorsal striatum, F(1, 9) = 1.705, p=0.22). Bonferroni post-test showed p-583 
ERK1/2 immuno-positive neurons were significantly increased by cocaine in both Htr2b-/- and 584 
Htr2b+/+ mice. These results are in agreement with microdialysis data for whole NAcc. Altogether 585 
Doly  p25 
 25 
these results suggest that reduced extracellular accumulation of DA blunts cocaine-dependent 586 
activation of the ERK1/2 pathway in medium spiny neurons of the NAcc shell from Htr2b-/- mice 587 
without modification of activity in the dorsal striatum.  588 
 589 
The lack of 5-HT2B receptors increases locomotor effects of D1 agonist. Since cocaine-dependent 590 
ERK1/2 activation relies on D1 receptor-expressing striatal neurons, we assessed the locomotor 591 
response to D1 receptor agonist SKF81297 (2 mg/kg). Two-way ANOVA RM showed a significant 592 
effect of genotype (F(1, 14) = 5.30 p=0.037) and time (F(18, 252) = 59.93, p<0.0001) with interactions 593 
(F(18, 252) = 4.34, p<0.0001) (Fig. 4a). Bonferroni post-test showed that SKF81297 increased 594 
locomotor activity significantly more in Htr2b-/- than in Htr2b+/+ mice at 5-15 min. A second 595 
SKF81297 injection, seven days after the first, increased more locomotion in Htr2b-/- than in Htr2b+/+ 596 
mice (Fig. 4a significant effect of genotype F(1,14) = 5.95 p=0.029 and time F(18, 252) = 100.4, 597 
p<0.0001 with interactions F(18, 252) = 5.58, p<0.0001). Bonferroni post-test showed that SKF81297 598 
increased locomotor activity significantly more in Htr2b-/- than in Htr2b+/+ mice at 5-20 min. The 599 
fold increase in cocaine induced-locomotor activity at the second SKF81297 injection with respect to 600 
the first was similar in both genotypes (Fig. 4a unpaired t-test t14 = 1.00, P=0.33). Two-way 601 
ANOVA RM analysis of the total locomotor activity over 60 min showed significant effects of 602 
genotype and time of injection (Fig. 4a main effects of genotype F(1, 14) = 12.30, p=0.0035 and of 603 
injection time F(1, 14) = 13.19, p=0.0027 with no interactions F(1,14) = 0.057, p=0.82). Bonferroni post-604 
test showed that total locomotor activity over 60 min after a 2nd injection of SKF81297 was 605 
significantly higher in Htr2b-/- compared to Htr2b+/+ mice and to the 1st injection. Nevertheless, basal 606 
expression of D1 and D2 receptors in Htr2b-/- mice did not differ from Htr2b+/+ mice (Fig. 4b,c), and 607 
neither did Gαolf expression (Fig. 4b,d). Moreover, there was no difference in striatal DAT, SERT, 608 
NET expression between Htr2b+/+ and Htr2b-/- mice (Doly et al., 2008; Banas et al., 2011; Diaz et al., 609 
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2012). These results suggest that D1 receptors are sensitized in Htr2b-/- mice without modification of 610 
receptor, Gαolf, or transporter expression.  611 
 612 
Meso-accumbens DA neurons express 5-HT2B receptors. To understand how 5-HT2B receptors 613 
could affect cocaine-induced effects in the NAcc, we evaluated their expression in VTA DA neurons. 614 
In the absence of reliable antibody against 5-HT2B receptors in mice, we performed single-cell RT-615 
PCR by extracting cytoplasmic RNA of single identified DA neurons expressing GFP from brain 616 
slices of Drd2-EGFP mice. We found that among D2- and tyrosine hydroxylase (TH)-positive 617 
neurons of the VTA, 40% expressed Htr2b mRNA (Fig. 5a). The two primary efferent fiber 618 
projections of DA neurons from VTA are the mesocortical and mesolimbic pathways, innervating the 619 
prefrontal cortex and NAcc, respectively (Lammel et al., 2014). We anticipated that among the VTA 620 
neurons expressing Htr2b, some would send projections to the NAcc and dorsal striatum. To 621 
visualize these cells, we stereotactically injected red-dextran into the NAcc shell (Fig. 5b-d) or 622 
dorsal striatum (Fig. 5e,f) of Drd2-EGFP mice and traced retrograde transport. We found that DA 623 
neurons projecting to the NAcc shell originated from the parabrachial pigmented area of the VTA 624 
(Fig. 5c,d), as previously reported (Ikemoto, 2007). Strikingly, by performing single cell RT-PCR on 625 
double-labeled neuron (Fig. 5b), we found that all double-labeled (Drd2-EGFP and NAcc shell-626 
injected red-dextran) neurons expressed 5-HT2B receptors (n = 13 out of 13). These data support a 627 
selective expression of 5-HT2B receptors in mesolimbic DA neurons sending axons to NAcc shell.  628 
 629 
The conditional knockout of 5-HT2B receptor genes in DA neurons increases locomotor effects 630 
of cocaine. To functionally validate the 5-HT2B-receptor expression in DA neurons, we generated 631 
conditional knockout mice by inserting recombination sites (loxP) flanking the Htr2b first coding 632 
exon (Htr2bfl/fl) (Fig. 6a-c). We crossed mice expressing the Cre recombinase under a DA transporter 633 
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promoter (Dat-Slc6a3) (Dat-Cre+/0) with these Htr2bfl/fl mice, generating Htr2bDAKO. We verified the 634 
proper recombination by colocalization of Dat-GFP with TH-positive DA neurons (Fig. 6b,c). A 635 
first injection of cocaine (20 mg/kg) induced a stronger increase in locomotor activity in Htr2bDAKO 636 
mice than in control littermates Htr2bfl/fl mice (Fig. 6d two-way ANOVA RM, significant effect of 637 
genotype F(1, 18) = 4.03, p=0.05 and time F(16, 288) = 12.09, p<0.0001 with interactions F(16, 288) = 3.27, 638 
p<0.0001). Bonferroni post-test showed a significant increase in locomotion at 5-25 min. The 639 
locomotor effect of a challenge dose of cocaine seven days later (second injection) was also 640 
significantly enhanced in Htr2bDAKO mice compared to Htr2bfl/fl control mice (Fig. 6d, two-way 641 
ANOVA RM, significant effect of genotype F(1, 18) = 10.63, p=0.004 and time F(16, 288) = 22.16, 642 
p<0.0001 with interactions F(16, 288) = 4.90, p<0.0001). Bonferroni post-test showed a significant 643 
increase at 5-30 min. The fold increase in cocaine induced-locomotor activity at the second injection 644 
with respect to the first was similar in both genotypes (Fig. 6d unpaired t-test t18 = 0.324, P=0.75). 645 
Two-way ANOVA RM analysis of the locomotion over 60 min showed significant effects of 646 
genotype (F(1, 18) = 10.31, p=0.0048) and time of injection (F(1, 18) = 23.82, p=0.0001) with 647 
interactions (F(1,18) = 3.74, p=0.069). Bonferroni post-test showed that total locomotor activity 648 
recorded over 60 min after a 2nd injection was significantly higher in Htr2bDAKO compared to 649 
Htr2bfl/fl littermate mice and compared to the 1st injection (Fig. 6d). Thus, mice that underwent 650 
selective Htr2b inactivation in DA neurons display increased locomotor responses to cocaine. These 651 
data confirmed that inactivation of the receptor in DA neurons is, at least in part, responsible for 652 
locomotor effects and potentially for modulation of DA neuron activity observed in Htr2b-/- mice. 653 
 654 
The lack of 5-HT2B receptors modulates VTA DA cell excitability. We next tested the hypothesis 655 
that 5-HT2B receptors expressed by VTA DA neurons directly modulate activity of these neurons, 656 
first, by recording electrophysiological activity in-vivo in Htr2b+/+ and Htr2b-/- mice. Mice were 657 
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anesthetized and electrophysiologically active cells encountered in a stereotactically defined block of 658 
brain tissue including the VTA were recorded; only cells that met all criteria for VTA DA neurons 659 
were recorded: (i) a typical triphasic action potential with a marked negative deflection; (ii) a 660 
characteristic long-duration (>2.0 ms) action potential; (iii) an action potential width from start to 661 
negative of >1.1 ms; (iv) a slow firing rate (<10 Hz) with an irregular single spiking pattern (tonic) 662 
and occasional short, slow bursting (phasic) activity (Grace and Bunney, 1984b, a; Gonon, 1988; 663 
Mameli-Engvall et al., 2006). Juxtacellular single unit recordings were obtained in anesthetized 664 
Htr2b+/+ and Htr2b-/- mice, respectively (Fig. 7a). Activity of DA cells was then characterized using 665 
the firing rate and the percentage of spikes within a burst (% SWB). DA cells fired at an average rate 666 
of 1.6 ± 0.2 Hz in Htr2b+/+ and 1.8 ± 0.1 Hz in Htr2b-/- mice (n = 57-58). The mean percentage of 667 
burst firing in individual cells ranged from 0% to 16% in Htr2b+/+ and 0% to 60% in Htr2b-/- mice, 668 
and was significantly higher in Htr2b-/- (5.2 ± 1.5%) than Htr2b+/+ (1.4 ± 0.5%) mice (Fig. 7a, 669 
unpaired t-test-Welch corrected t66 = 2.27, P=0.026).  670 
 After baseline recordings, the same mice were ip injected with cocaine and the evoked 671 
modification of firing rate was analyzed. Cocaine (20 mg/kg) decreased the firing rate by 62.3% in 672 
Htr2b+/+ mice, while this decrease was significantly greater (90.9%) in Htr2b-/- mice (Fig. 7b, 673 
unpaired t-test-Welch corrected t16 = 2.73, P=0.015). The decrease in firing rate lasted for more than 674 
30 min after drug delivery and was not always followed by a return to pre-injection levels in Htr2b-/- 675 
mice. However, systemic ip injection of the D2 agonist quinpirole (0.25-0.5 mg/kg) produced a 676 
similar decrease of firing rate in Htr2b+/+ and Htr2b-/- mice (Fig. 7c). Our results indicate that long 677 
term blockade of 5-HT2B receptor lead to a stronger cocaine-dependent inhibition of DA neurons 678 
firing rate and supports the hypothesis that 5-HT modulates VTA DA cell excitability via 5-HT2B 679 
receptors without modification of D2 autoreceptor function.  680 
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 To test whether the lack of 5-HT2B receptors would produce long-lasting synaptic 681 
modifications in DA neurons, we used whole-cell patch recordings in acute brain slices. We 682 
measured AMPA- and NMDAR-mediated excitatory postsynaptic currents (EPSCs) in voltage clamp 683 
mode at +40 mV on horizontal brain slices, which included VTA from Htr2b+/+ and Htr2b-/- mice, in 684 
DA neurons (large cells (>30 pF capacitance) from the lateral part of VTA that are prone to project 685 
to the NAcc shell. In Htr2b-/-, the AMPA/NMDA ratio was significantly increased compared to 686 
control mice (Htr2b+/+: 0.63 ± 0.06, n=7 cells; Htr2b-/-: 1.01 ± 0.15, n=7 cells) (Fig. 7d, unpaired t-687 
test t12 = 2.35, P=0.037). Altogether, these results indicated that the lack of 5-HT2B receptors 688 
promotes an increase in DA neuron bursting in-vivo properties, a stronger reactivity to cocaine, and a 689 
concomitant potentiation of AMPA synaptic transmission of VTA DA neurons measured ex-vivo.  690 
 691 
Htr2b inactivation modifies reinforcing properties of cocaine. To know if locomotor activating 692 
effects of cocaine are associated with disruptions in primary reinforcing effects of the drug, we tested 693 
whether 5-HT2B-receptor deletion altered operant cocaine self-administration. Htr2b+/+ and Htr2b-/- 694 
animals were first trained to respond for food pellets under a fixed ratio (FR) 1 schedule of 695 
reinforcement, see (Fig. 8a) for self-administration experiments timeline. An increase in nose-poke 696 
responding was observed during the first sessions leading to a learning-curve pattern in both group of 697 
animals (day, F(7, 203) = 17.9, p<0.001). Although active responding in Htr2b+/+ group was slightly 698 
higher, this difference was not significant (genotype, F(1, 29) = 0.8, p=0.36) and the discrimination 699 
between active and inactive nose-poke responding was rapidly acquired by both Htr2b+/+ and Htr2b-700 
/- mice (Fig. 8b, hole, F(1, 29) = 144.4, p<0.001). No statistical differences between genotypes were 701 
obtained when data from the acquisition days was analyzed (F(1, 29) = 2.7, p=0.112) (Fig. 8c). 702 
Following catheter implantation, animals were tested on intravenous saline self-administration until 703 
responding rates decreased in order to avoid interference from food responding to cocaine self-704 
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administration. The mice included in the statistical analysis (18 Htr2b+/+ and 13 Htr2b-/- mice) 705 
showed patent catheters up to the end of the experiment. Three-way repeated measures ANOVA 706 
analysis of the acquisition of cocaine (0.250 mg/kg/infusion) self-administration data showed a 707 
significant interaction between hole x day: (F(7,203) = 2.58, p<0.05), but not between hole x genotype: 708 
(F(1,29) = 1.51669, p=0.228), day x genotype: (F(7,203) = 0.69168, p=0.679), or hole x day x genotype: 709 
(F(7,203) = 0.2108, p=0.983) (Fig. 8d). Significant main effects of hole: (F(1,29) = 47.19, p<0.001), day: 710 
(F(7,203) = 4.02, p<0.001) and genotype (F(1,29) = 4.56 p<0.05) were revealed. During the 8 days of 711 
acquisition training, 61% of WT and 38.5 % of KO mice met the stability criteria for cocaine self-712 
administration at this dose. Cocaine intake (mg/kg) during the last 3 days of training at the dose of 713 
0.25 mg/kg/infusion was not significantly different between genotypes (ANOVA: (F(1,29) = 1.61, 714 
p=0.213) (Fig. 8e). Statistical analysis of cocaine dose-response results (Fig. 8f) showed that Htr2b-/- 715 
mice earned a significantly lower number of cocaine infusions (genotype, F(1, 29) = 5.4, p<0.05), 716 
especially at the dose of 0.125 (genotype, F(1, 29)= 6.3, p<0.05) and 0.500 mg/kg/infusion (genotype, 717 
F(1, 29) = 4.2, p<0.05) with respect to Htr2b+/+ mice. Although Htr2b-/- animals obtained a lower 718 
breaking point in the progressive ratio schedule of reinforcement test (Fig. 8g), this difference was 719 
not significant (genotype, F(1, 29) = 2.1, p=0.162). Finally, daily liquid intake was analyzed in 720 
Htr2b+/+ and Htr2b-/- animals following self-administration experiments. Both groups of mice drank 721 
similar amounts of water during a 24 h period (genotype, F(1, 29) = 0.5, p=0.502) (Fig. 8h), and both 722 
groups exhibited a comparable preference for sucrose-enriched water (genotype, F(1, 29) = 1, p=0.325) 723 
(Fig. 8i). Although learning ability is similar in Htr2b-/- mice to Htr2b+/+, they self-administer less 724 
cocaine, show a trend toward lower breaking point, and display no difference in post-cocaine reward 725 
system.   726 
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Discussion  727 
Here, we report that mice lacking 5-HT2B receptors totally or exclusively in DA neurons exhibit 728 
heightened cocaine-induced locomotor responses. The lack of 5-HT2B receptors induces a reduced 729 
cocaine-induced extracellular DA-accumulation. It also produces an over-reactivity of the NAcc 730 
shell medium spiny neurons to cocaine or D1 agonist, without any modification of DA signaling in 731 
the dorsal striatum. We describe the selective expression of 5-HT2B receptors in VTA DA neurons 732 
sending axons to NAcc shell. An increase in basal DA neuron bursting in-vivo properties and a 733 
concomitant increase in AMPA synaptic transmission to VTA DA neurons measured ex-vivo were 734 
found in mice lacking 5-HT2B receptors. The lack of 5-HT2B receptors leads to a stronger inhibition 735 
of DA neurons firing rate in response to cocaine without modification of D2 autoreceptor function. 736 
Finally, the absence of 5-HT2B receptors is associated with a decreased cocaine self-administration 737 
with a trend toward a lower breaking point in the progressive ratio schedule of reinforcement test. 738 
These data point toward the requirement of 5-HT via 5-HT2B receptors to modulate both DA neurons 739 
and their targets. 740 
 DA and 5-HT interactions are known to be important in mesolimbic and nigrostriatal DA 741 
pathways. 5-HT immunoreactive fibers are dense in both VTA and SNc (Hervé et al., 1987). 5-HT2A 742 
and 5-HT2C receptors have previously been shown to modulate the effects of cocaine (Cunningham 743 
and Anastasio, 2014). We show, here, that genetic ablation of 5-HT2B receptors, even restricted to 744 
DA neurons, increases cocaine-induced locomotor activity. However, acute pharmacologic inhibition 745 
does not reproduce this effect. These data are in agreement with previous neuropharmacological data 746 
indicating the inability of 5-HT2B receptor antagonists to affect cocaine responses while acute 747 
blockade of 5-HT2A and 5-HT2C receptors generated opposing modulatory actions on cocaine-748 
induced activity (Filip et al., 2010; Cunningham and Anastasio, 2014; Devroye et al., 2015). 749 
Nevertheless, we show here that a chronic (4 weeks) exposure to a 5-HT2B-receptor antagonist is 750 
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sufficient to increase the locomotor response to cocaine to the same extent as the increase observed 751 
in Htr2b-/- mice. Aside of opposing actions of 5-HT2A and 5-HT2C receptors, 5-HT2B receptors likely 752 
modulate directly and indirectly cocaine-induced locomotion via DA-dependent circuitry, since we 753 
found that 5-HT2B receptors are expressed in VTA DA neurons projecting to the NAcc shell and that 754 
their selective elimination in DA neurons by conditional knockout is sufficient to reproduce the 755 
increased locomotor response to cocaine. It is clear that the 5-HT2B receptor mode of action differs 756 
from that of 5-HT2A and 5-HT2C receptors and must affect different DA neuron subpopulation and/or 757 
different effectors. 758 
 One of our most striking finding is the dissociation between decreased cocaine-induced 759 
extracellular DA accumulation in NAcc associated to blunted activation of the ERK1/2 pathway 760 
selectively in medium spiny neurons of the NAcc shell, and increased locomotor activity. Cocaine, 761 
like other drugs of abuse, is known to preferentially increase extracellular DA in the NAcc shell as 762 
compared to the core (Di Chiara and Bassareo, 2007). This preferential action has also been 763 
demonstrated during acquisition of cocaine self-administration (Lecca et al., 2007). We identified 764 
that 100% of the retrogradely labeled DA neurons in the NAcc shell originating from VTA, express 765 
5-HT2B receptors. Interestingly, the reduced ERK1/2 activation of NAcc shell neurons following 766 
cocaine injection in Htr2b-/- mice does not seem to take place in other striatal areas such as the core 767 
and dorsal striatum as indicated by the lack of effect on cocaine-induced increase of phosphorylated 768 
ERK1/2. The reduction of DA transmission in the NAcc shell upon cocaine injection may result from 769 
a heightened sensitivity to the inhibitory effect of cocaine on the firing of DA neurons projecting to 770 
the NAcc shell, since we observed that cocaine produced a stronger decrease in firing rate of VTA 771 
DA neurons in Htr2b-/- mice. Recent pharmacological studies in rats have shown that acute 5-HT2B-772 
receptor antagonist injection had no effect on cocaine-induced DA outflow in the NAcc shell or core, 773 
or in the dorsal striatum (Devroye et al., 2015). However, these authors showed that an antagonist 774 
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injection reduced basal DA levels in the NAcc shell (Devroye et al., 2015), and was devoid of effect 775 
in the dorsal striatum (Devroye et al., 2016).  These acute effects may be involved in neuroadaptions 776 
observed upon chronic antagonist exposure. Although, the cocaine dose of 0.25 mg/kg/infusion has 777 
reinforcing effects in Htr2b-/- mice, the doses of 0.125 and 0.50 mg/kg/infusion do not. The fact that 778 
cocaine does not result in extracellular DA accumulation in the NAcc of these animals may underlie 779 
this observation. However there could also be DA-independent mechanism at work, possibly via 5-780 
HT release, which is unchanged in Htr2b+/+ and Htr2b-/- mice. Thus, the impaired 5-HT:DA balance 781 
could explain why Htr2b-/- mice do not self-administer cocaine due to aversive properties of still-782 
existing cocaine-evoked 5-HT release.  783 
 Furthermore, Htr2c-/- mice display also increased sensitivity to locomotor stimulant effects of 784 
cocaine and exhibit enhanced cocaine-induced elevations of extracellular DA levels in the NAcc, but 785 
not in dorsal striatum (Rocha et al., 2002). The drug is more reinforcing in these mice. The 5-HT2C 786 
receptor has been shown to be expressed in some VTA neurons, which synthesize and potentially 787 
release both DA and γ-aminobutyric acid (GABA) and project to the NAcc (Bubar et al., 2011). 788 
Since, we recently reported a dominance of 5-HT2C over 5-HT2A and 5-HT2B receptors upon 789 
coexpression, which was also observed in-vivo (Moutkine et al., 2017), 5-HT2B/5-HT2C receptors 790 
heterodimerization may participate in some of these cocaine responses.  791 
 Another explanation to the dissociation between cocaine-induced decrease in DA 792 
accumulation, increase in locomotion, and reduction in cocaine self-administration is the increased 793 
post-synaptic responsiveness in other striatal areas. An important finding is the observation that a 794 
delay is necessary to allow adaptations that are responsible for these apparent paradoxical responses, 795 
the increased cocaine response being only an indirect consequence of 5-HT2B receptor-dependent 796 
reduction in DA tone observed in NAcc and downstream adaptation. Our observation of sensitized 797 
locomotor response to D1 agonists in Htr2b-/- mice may be the reason for the apparent discrepancy 798 
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between reduction of DA transmission in the NAcc shell and increased locomotion. The trend in 799 
reduction of reinforcing properties of cocaine as indicated by reduction in breaking point for cocaine 800 
responding in a progressive ratio schedule is consistent with the reduction of DA stimulant effects of 801 
cocaine in Htr2b-/- mice. These observations suggest that NAcc shell DA acting on D1 receptors (p–802 
ERK findings) is critical for cocaine reinforcement. This conclusion is consistent with recent results 803 
obtained in rats, in which D1 receptors have been silenced by siRNA in the NAcc shell while sparing 804 
the core, and which were prevented from the acquisition of cocaine self-administration (Pisanu et al., 805 
2015). Interestingly, excitatory afferents of VTA DA neurons that project to the NAcc are 806 
potentiated upon exposure of animals to addictive drugs (Lammel et al., 2012). This induction 807 
depends on NMDA and D1 receptors (Ungless et al., 2001), which are activated when DA neurons 808 
become active, releasing DA from their dendrites. The NMDARs that drive this induction are located 809 
on DA neurons themselves, supporting that this form of plasticity is a VTA-autonomous process. 810 
The ratio of the amplitude of AMPA/NMDA-mediated postsynaptic currents, a parameter often used 811 
to quantify synaptic strength in acute brain slice preparation, becomes higher than normal upon 812 
exposure to addictive drugs (Ungless et al., 2001). Here, we found that permanent ablation of 5-HT2B 813 
receptors is associated with higher reactivity to cocaine of VTA DA neurons and higher 814 
AMPA/NMDA ratio. These data support that the 5-HT2B receptor acts as an important factor 815 
preventing drug-evoked synaptic plasticity.  816 
 Previous evidence indicated that 5-HT2B receptors could directly modulate 5-HT neurons and 817 
indirectly DA neurons. Indeed, genetic (knockout) or pharmacologic manipulation (antagonist) of 5-818 
HT2B receptors interferes with the effects of molecules that directly target the 5-HT system including 819 
serotonin selective reuptake inhibitors (SSRI) antidepressant, or amphetamine-derivatives 5-HT 820 
releasers MDMA and dexfenfluramine (Doly et al., 2008; Doly et al., 2009; Banas et al., 2011; Diaz 821 
et al., 2012). For example, the enhanced locomotor response to the psychostimulant MDMA was 822 
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abolished in Htr2b-/- mice (Doly et al., 2008). These mutant mice did not exhibit behavioral 823 
sensitization or conditioned place preference following MDMA (10 mg/kg) injections as following 824 
injection of a 5-HT2B-receptor antagonist (RS127445) in wild type mice. Nevertheless, high doses 825 
(30 mg/kg) of MDMA induce DA-dependent but 5-HT-independent behavioral effects (Doly et al., 826 
2009). It was also reported that 5-HT2B receptor selective antagonists can reduce significantly the 827 
DA outflow induced by amphetamine in the NAcc shell, but not in the dorsal striatum (Auclair et al., 828 
2010). We independently found that Htr2b-/- mice display a higher amphetamine-induced locomotion 829 
(Pitychoutis et al., 2015). Together with our present findings, these observations clearly distinguish 830 
between a direct action of 5-HT2B receptors on 5-HT neurons that is mimicked by antagonists, from 831 
an action at DA neurons that requires long term inhibition of 5-HT2B receptors and neuroadaptations 832 
i.e., that is not reproduced by direct antagonist injections. This finding is of importance for genetic 833 
polymorphisms that permanently affect gene expression such as the HTR2B (Gln20Ter) mutation 834 
(Bevilacqua et al., 2010). 835 
 Several parameters remain to be determined to fully explain our findings, e.g. the exact 836 
neural circuits that are modified, or the time during which blockade of 5-HT2B receptor activity is 837 
necessary to produce the observed changes in reactivity to cocaine. Nevertheless, this work 838 
established for the first time that permanently inactive 5-HT2B receptor is associated with a local 839 
hypodopaminergy that paradoxically and ultimately results in increased cocaine psychostimulant 840 
responses and a trend toward blunted motivation to the drug. To sum up, the chronic 5-HT2B-receptor 841 
inhibition makes mice behaving as animals already exposed to cocaine with higher cocaine-induced 842 
locomotion associated with changes in DA neuron reactivity. 843 
  844 
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Figure legends 961 
Fig. 1. Dose-dependent effects of 5-HT2B receptor knockout on cocaine responses. a : Cocaine 962 
dose-dependent locomotor activity. The locomotor activity was recorded every 5 min. Cocaine was 963 
injected after 30 min of habituation. Over the first 10 minutes, cocaine dose-dependently increased 964 
the locomotor activity significantly more in Htr2b-/- mice (black square) than in Htr2b+/+ mice (white 965 
square) (means ± SEM). Data were analyzed by multiple t-tests, (n= 8-8, vehicle; n = 8-9, cocaine 966 
7.5 mg/kg; n = 9-9, cocaine 15 mg/kg; n = 3-5, cocaine 20 mg/kg; *P<0.05). b : Higher locomotor 967 
response to cocaine injection (7.5 mg/kg) of Htr2b-/- mice. An injection of cocaine (7.5 mg/kg) 968 
increased significantly more the locomotor activity in Htr2b-/- (cocaine, black square, n = 12) than in 969 
Htr2b+/+ mice (cocaine, white square, n = 12; 1st injection, left, arrow cocaine injection t = 0), while 970 
no locomotor difference was found following vehicle in Htr2b-/- (black circle, n = 8) or in Htr2b+/+ 971 
(white circle, n = 8). Data were analyzed by two-way ANOVA repeated measures (RM). The 972 
stimulant locomotor effect of a challenge dose of cocaine seven days later (2nd injection, right, arrow 973 
cocaine injection t = 0) was significantly higher in Htr2b-/- than in Htr2b+/+ mice, while no 974 
locomotor difference was found following vehicle in Htr2b-/- or in Htr2b+/+mice. The increase in 975 
cocaine induced-locomotor activity at the second injection was similar in respect to the first (Fold 976 
first) (left, n=12-12; unpaired t-test). Total locomotor activity recorded over 60 min after a 2nd 977 
injection (right) was significantly higher in Htr2b-/- (black bars) compared to Htr2b+/+ mice (white 978 
bars) and to the 1st injection, as analyzed using two-way ANOVA RM for cocaine (means ± SEM, n 979 
= 12-12); Bonferroni post-hoc tests were applied to each graph, *P<0.05. c : Higher locomotor 980 
response to cocaine injection (15 mg/kg) of Htr2b-/- mice. An injection of cocaine (15mg/kg) 981 
increased significantly more the locomotor activity in Htr2b-/- (cocaine, black square, n = 12) than in 982 
Htr2b+/+ mice (cocaine, white square, n = 12) (1st injection, left, arrow cocaine injection t = 0), while 983 
no locomotor difference was found following vehicle in Htr2b-/- (black circle, n = 8) or in Htr2b+/+ 984 
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(white circle, n = 8) mice. Data were analyzed by two-way ANOVA RM. The stimulant locomotor 985 
effect of a challenge dose of cocaine seven days later (2nd injection, right, arrow cocaine injection t = 986 
0) was also significantly higher in Htr2b-/- compared to Htr2b+/+ mice, while no locomotor difference 987 
was found following vehicle in Htr2b-/- or in Htr2b+/+ mice. The increase in cocaine induced-988 
locomotor activity at the second injection was similar in respect to the first (Fold first) (left, n=12-12; 989 
unpaired t-test). Total locomotor activity recorded over 60 min after a 2nd injection (right) was 990 
significantly higher in Htr2b-/- (black bars) compared to Htr2b+/+ mice (white bars) and to the 1st 991 
injection, as analyzed using two-way ANOVA RM (n = 12-12) (means ± SEM). Bonferroni post-hoc 992 
tests were applied to each graph, *P<0.05.  993 
 994 
Fig. 2. Effects of 5-HT2B receptor pharmacological blockade on cocaine response. a : Lack of 995 
effect of an injection of 5-HT2B receptor antagonists on cocaine-induced locomotion. Locomotor 996 
activity was not different in response to saline vehicle (Veh-white circle, n = 8) or to a selective 5-997 
HT2B receptor antagonist (RS127445 0.5 mg/kg-RS, black circle, n = 8) (left) or after 15 mg/kg of 998 
cocaine ip co-injected with vehicle (Veh-white square, n = 12) or with RS127445 (0.5 mg/kg-RS, 999 
black square, n = 11) (left) in Htr2b+/+ mice. Similarly, no locomotor difference was found following 1000 
saline vehicle (Veh-white circle, n = 7) or a 5-HT2B/2C receptor antagonist (SB206553 3 mg/kg-SB) 1001 
(right) (black circle, n = 7) or after 15 mg/kg of cocaine ip co-injected with vehicle (Veh-white 1002 
square, n = 7) or with SB206553 (3 mg/kg-SB) (right) (black square, n = 7) in Htr2b+/+ mice. Data 1003 
were analyzed using two-way ANOVA RM for cocaine (means ± SEM). b : Mice exposed 4 weeks 1004 
to RS127445 show increased locomotor responses to cocaine. Locomotor activity was not 1005 
different in response to saline vehicle (Veh-white circle, n = 8) or to 4 weeks RS127445-treated 1006 
(RS127445 1 mg/kg-RS 4W, black circle, n = 7). However, an injection of cocaine (15 mg/kg) 1007 
increased significantly more locomotor activity in 4 weeks RS127445-treated (cocaine, black square 1008 
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n = 8) than in vehicle-treated Htr2b+/+ mice (cocaine, white square, n = 8) (1st injection, left, arrow 1009 
cocaine injection t = 0), as shown by two-way ANOVA RM. The stimulant locomotor effect of a 1010 
challenge dose of cocaine seven days later was also significantly higher in 4 weeks RS127445-1011 
treated Htr2b+/+ mice (cocaine, black square, n = 8) (2nd injection, right, arrow cocaine injection t = 1012 
0) compared to vehicle-treated Htr2b+/+ mice (cocaine, white square, n = 8-8), while no locomotor 1013 
difference was found following saline vehicle (Veh-white circle, n = 7) or a 4 weeks RS127445-1014 
treated (RS127445 1 mg/kg-RS 4W, black circle, n = 7). The increase in cocaine induced-locomotor 1015 
activity at the second injection was similar in respect to the first (Fold first) (n = 8-8, left; unpaired t-1016 
test). Total locomotor activity recorded over 60 min after a 1st injection of cocaine and a 2nd 1017 
injection (right) was significantly higher in 4 weeks RS127445-treated compared to vehicle-treated 1018 
Htr2b+/+ mice and to the first injection, as analyzed using two-way ANOVA RM (n = 8-8) (means ± 1019 
SEM). Bonferroni post-hoc tests were applied to each graph, *P<0.05.  1020 
 1021 
Fig. 3. Effect of 5-HT2B receptor knockout on cocaine-dependent striatal activation. a : Lower 1022 
extracellular DA but identical 5-HT accumulation in NAcc of cocaine-treated Htr2b-/- mice. 5-1023 
HT and DA extracellular concentrations were assessed by microdialysis in the NAcc of awake mice. 1024 
After cocaine (20 mg/kg) injection (t = 0), extracellular DA was significantly more elevated in 1025 
Htr2b+/+ (white square, n = 7) compared to Htr2b-/- (black square, n = 8) or saline control (black and 1026 
white circle, n =7-8) mice, as analyzed by two-way ANOVA RM. No difference in NAcc 5-HT 1027 
extracellular concentrations in Htr2b+/+ (white square) and Htr2b-/- (black square) mice, as analyzed 1028 
using two-way ANOVA RM for cocaine (means ± SEM). Bonferroni post-hoc tests were applied to 1029 
each graph, *P<0.05 vs. Htr2b+/+ cocaine. b-g : Reduced ERK1/2 phosphorylation in ventral, but 1030 
not in dorsal striatum of cocaine-treated Htr2b-/- mice. b : The locomotion was first recorded 1031 
during the first 10 minutes after saline (vehicle) or cocaine (20 mg/kg) injection. Locomotor activity 1032 
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was significantly higher in Htr2b-/- (black square) than in Htr2b+/+ mice (white square), as analyzed 1033 
using two-way ANOVA (n = 3-5) (means ± SEM). Bonferroni post-hoc tests were applied to each 1034 
graph, *P<0.05. Immediately after the 10 min of locomotor recording, the brains were fixed and 1035 
sectioned. p-ERK1/2 immuno-positive neurons were counted. c : location of the images within the 1036 
striatal tissue (red squares). d : raw images obtained in the confocal microscope (top panels), cell 1037 
counts performed on each image (middle panels, red dots) and segmentation on each image through 1038 
signal thresholding (bottom panels). e : quantification revealed significantly lower number of cells 1039 
positive for p-ERK1/2 in the NAcc shell of cocaine-treated Htr2b-/- (black) compared to Htr2b+/+ 1040 
(white) mice (n = 3-4 mice), as analyzed using two-way ANOVA. No difference between genotype 1041 
was found in NAcc core or dorsal striatum. Bar scales: 100 μm. Bonferroni post-hoc tests were 1042 
applied to each graph, *P<0.05.  1043 
 1044 
Fig. 4. Assessment of DA system in Htr2b-/- mice. a : Increased locomotor activity in response to 1045 
DA receptor D1 agonist in Htr2b-/- mice. An ip injection of D1 agonist SKF81297 (SKF, 2mg/kg) 1046 
increased significantly more the locomotor activity in Htr2b-/- (SKF, black square, n = 8) than in 1047 
Htr2b+/+ mice (SKF, white square, n = 8; 1st injection, left, arrow cocaine injection t = 0), while no 1048 
locomotor difference was found following vehicle in Htr2b-/- (Veh-black circle, n = 8) or in Htr2b+/+ 1049 
(Veh-white circle, n = 8), as analyzed using two-way ANOVA RM. The stimulant effect of a 1050 
challenge dose of SKF81297 seven days later (2nd injection, right, arrow cocaine injection t = 0) was 1051 
also significantly higher in Htr2b-/- (SKF, black square, n = 8) compared to Htr2b+/+ mice (SKF, 1052 
white square, n = 8; 2nd injection, left, arrow cocaine injection t = 0), while no locomotor difference 1053 
was found following vehicle in Htr2b-/- (Veh-black circle, n = 8) or in Htr2b+/+ (white circle, n = 8). 1054 
The increase in SKF81297 induced-locomotor activity at the second injection was similar in respect 1055 
to the first (Fold first) (left, n = 8-8; unpaired t-test). Total locomotor activity recorded over 60 min 1056 
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after a 2nd injection (right) was significantly higher in Htr2b-/- (black bars) compared to Htr2b+/+ 1057 
mice (white bars) and to the 1st injection, as analyzed using two-way ANOVA RM for cocaine 1058 
(means ± SEM, n = 8-8). Bonferroni post-hoc tests were applied to each graph, *P<0.05. b-d Similar 1059 
D1 and D2 receptor expression level in Htr2b+/+ and Htr2b-/- mice. b, Western blots from Htr2b+/+ 1060 
and Htr2b-/- mouse striatum proteins (2 examples for each genotype) were revealed using antibody 1061 
against D1 receptor (left, black arrow) or using Gαolf antibody (right, black arrow). Normalization 1062 
(using tubulin antibody; arrow head) revealed no significant difference between genotypes (n = 4 1063 
mice per genotype; Student’s t-test). c, Radioligand binding assays with the selective D1 receptor 1064 
ligand [3H]SCH23390 on membranes prepared from cortex and striatum showed no differences 1065 
between Htr2b+/+ and Htr2b-/- mice (Bmax = Htr2b+/+ cortex 18±2.7; Htr2b-/- cortex 14±2.5; 1066 
Htr2b+/+ striatum 211 ± 6; Htr2b-/- striatum 223 ± 7.4 fmoles/mg of proteins) (left). Radioligand 1067 
binding assays with the selective D2 receptor ligand [3H]raclopride on membranes prepared from 1068 
striatum showed no differences between Htr2b+/+ and Htr2b-/- mice (Bmax = Htr2b+/+ striatum 11.4 1069 
± 5.6; Htr2b-/- striatum 11.4 ± 5.7 fmoles/mg of proteins, 3 independent experiments in duplicate) 1070 
(right). d, Immunohistochemistry with a selective antibody directed against Gαolf protein on 1071 
striatum slices showed no pattern differences between Htr2b+/+ and Htr2b-/- mice, respectively, 1072 
(scale bars: 200 μm).  1073 
 1074 
Fig. 5. 5-HT2B receptors are expressed by mesolimbic DA neurons. a : Coexpression of D2 1075 
receptors and tyrosine hydroxylase with 5-HT2B-receptor mRNA in a subset of individual VTA 1076 
neurons. RT-PCR was performed on cytoplasmic RNA extracted from individually identified Drd2-1077 
EGFP-positive VTA neurons. The displayed pattern illustrates a negative (Neuron B) and a positive 1078 
neuron (Neuron A) expressing 5-HT2B receptor, which is representative of 4 out of 10 neurons in 1079 
VTA. All neurons classes express tyrosine hydroxylase (TH) and D2 receptors (D2). Negative RT-1080 
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PCR controls (GFP negative neuron) are also presented. M = molecular weight marker in base pairs. 1081 
b-d : VTA neurons expressing 5-HT2B receptor project to the NAcc. b, Stereotactic red-dextran 1082 
injection in NAcc of Drd2-EGFP mice allowed identifying, after retrograde tracing, VTA DA 1083 
neurons projecting to NAcc (double-labeled). Cytoplasmic RNA from double labeled neuron in the 1084 
VTA was analyzed by single cells RT-PCR (Neuron 1), which is representative of 13 out of 13 VTA 1085 
neurons expressing 5-HT2B receptor and that project to NAcc. c, Representative horizontal section, 1086 
showing NAcc shell stereotactic red-dextran injection site for retrograde tracing experiments using 1087 
fluorescently red-labeled latex beads. Scale bars: 600 μm d, Representative horizontal section, 1088 
showing red-dextran retrograde tracing in VTA of Drd2-EGFP mice that identified double-labeled 1089 
DA neurons projecting to NAcc used for single cells RT-PCR (Arrow and inset). Scale bars: 200 μm. 1090 
Star indicates the NAcc core nucleus. e-f Controls of red dextran injection into dorsal striatum. e, 1091 
Representative horizontal section, showing dorsal striatum stereotactic red-dextran injection site for 1092 
retrograde tracing experiments using fluorescently red-labeled latex beads. Scale bars: 600 μm f, 1093 
Representative horizontal section, showing red-dextran retrograde tracing in the substantia nigra 1094 
reticulata (SNR) of Drd2-EGFP mice that identify DA neurons projecting to dorsal striatum 1095 
(Arrow). Scale bars: 200 μm. SNR: substantia nigra reticulata; SNC substantia nigra compacta; ml: 1096 
medial lemniscus; Dst: dorsal striatum; f: fornix; cc: corpus callosum; LSD: lateral septal nucleus 1097 
dorsal.  1098 
 1099 
Fig. 6. Conditional deletion of 5-HT2B receptors in DA neurons, Htr2bDAKO mutant mice. a-c : 1100 
Mapping and genotyping of Htr2bDAKO mutant mice. Top: 5-HT2B receptor locus indicating the 1101 
positions of exons, (Exon 1, Ex1; Exon 2, Ex2) and restriction sites used for the targeting construct. 1102 
Middle: targeting vector designed to floxed exon 2 by homologous recombination in genomic DNA 1103 
generating the targeted locus (below). Exons 1– 2 are depicted by white (untranslated) and black 1104 
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boxes (coding) and Neomycin resistance by grey box (NEO). Bottom: sequenced-verified structure 1105 
of the Htr2b null allele (KO) after excision by Cre recombinase of the sequence ﬂanked by LoxP 1106 
sites (triangles). Horizontal arrows illustrate the position of primers used for genotyping (F1, R1, 1107 
R2). b : Genomic DNA of VTA from Htr2bDAKO mice was extracted and analyzed by PCR, revealing 1108 
the effective proper recombination (F1, R2 amplimers, 309 bp). c: Efficient Cre recombination in TH 1109 
positive neurons. Immunofluorescence revealed the recombinase-dependent GFP expression in VTA, 1110 
which colocalized with the TH antibody staining as seen by confocal microscopy in coronal section 1111 
of VTA of Dat-Cre+/0;RCE (Dat-GFP) mice (inset); scale bars: 250 μm, inset 50 μm. d : Restricted 1112 
5-HT2B receptor inactivation to DA neurons leads to increased locomotor response to cocaine. 1113 
An injection of cocaine (20 mg/kg) increased significantly more locomotor activity in Htr2bDAKO 1114 
(Dat-Cre+/0;Htr2bfl/fl cocaine, black square, n = 10) than in Cre negative littermate mice (Htr2bfl/fl 1115 
cocaine, white square, n = 10; 1st injection, left, arrow cocaine injection t = 0), as analyzed using 1116 
two-way ANOVA RM, while no locomotor difference was found following vehicle in Htr2bDAKO 1117 
(Veh-black circle, n = 10) or in Htr2bfl/fl (Veh-white circle, n = 10). The stimulant locomotor effect 1118 
of a challenge dose of cocaine seven days later (2nd injection, right, arrow cocaine injection t = 0) 1119 
was also significantly higher in Htr2bDAKO compared to Htr2bfl/fl mice, while no locomotor difference 1120 
was found following vehicle in Htr2bDAKO (Veh-black circle, n = 10) or in Htr2bfl/fl (white circle, n = 1121 
10). The increase in cocaine induced-locomotor activity at the second injection was similar in respect 1122 
to the first (Fold first) (n=10-10; unpaired t-test). Total locomotor activity recorded over 60 min after 1123 
a 2nd injection was significantly higher in Htr2bDAKO compared to Htr2bfl/fl littermate mice and 1124 
compared to the 1st injection, as analyzed using two-way ANOVA RM for cocaine (n = 10-10) 1125 
(means ± SEM). Bonferroni post-hoc tests were applied to each graph, *P<0.05.  1126 
 1127 
 1128 
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Fig. 7. Electrophysiological effects of 5-HT2B receptor knockout on VTA DA neurons. a : 1129 
Changes in basal in-vivo firing of Htr2b-/- VTA DA neurons. After in-vivo recordings, the mean 1130 
frequency (Hz) was plotted against the percentage of spikes within a burst (%SWB) of DA neurons 1131 
in Htr2b+/+ (red, n = 57) and Htr2b-/- mice (blue, n = 58). Barplot shows no change in the mean 1132 
frequency (left) and a significant increase in percentage of SWB (right) for the same groups 1133 
(unpaired t-test-Welch corrected). b : Cocaine induced a stronger decrease in firing rate of VTA 1134 
DA neurons in Htr2b-/- mice. Systemic ip injection of cocaine (20 mg/kg) in Htr2b+/+ (10 mice; red 1135 
line) and Htr2b-/- (9 mice; blue line) mice produced a decrease of firing rate. On average, cocaine-1136 
induced decrease in firing rate was significantly stronger in Htr2b-/- than in Htr2b+/+ mice (unpaired 1137 
t-test-Welch corrected). The percentage of variation in firing rate (right) is illustrated. c : No change 1138 
in quinpirole-dependent decrease in firing rate of VTA DA neurons in Htr2b-/- mice. Systemic ip 1139 
injection of the D2 agonist quinpirole (Quinp 250-500 μg/kg) in Htr2b+/+ (n = 6-5 mice; red line) and 1140 
Htr2b-/- (n = 7-6 mice; blue line) mice produced similar decrease of firing rate. The percentage of 1141 
variation in firing rate (right) is illustrated for the two concentrations. d : Strengthening of AMPA 1142 
transmission in the VTA neurons of Htr2b-/- mice. Representative sample traces for AMPAR- 1143 
(black) and NMDAR-EPSCs (gray) recorded at +40 mV in DA neurons from the lateral part of the 1144 
VTA that are prone to project to the NAcc shell of Htr2b-/- and Htr2b+/+ mice. (right): Bar graph and 1145 
scatter plot illustrate the significant increase in AMPA/NMDA ratio in the Htr2b-/- vs. Htr2b+/+ mice 1146 
(unpaired t-test, n = 7-7).  1147 
 1148 
Fig 8. Cocaine self-administration in Htr2b-/- mice.  1149 
a : Timeline for the self-administration experiments. b-c : Similar training to food pellets in 1150 
Htr2b+/+ and Htr2b-/- mice. Mice were first trained to respond for food pellets under FR1 schedule of 1151 
reinforcement in one-hour daily self-administration sessions until responding for food criteria was 1152 
Doly  p49 
 49 
acquired. A significant increase in nose-poke responding was observed during the first sessions 1153 
leading to a learning-curve pattern in both groups of mice. Data analyzed by three-way ANOVA 1154 
showed an effect of the day. The discrimination between active and inactive nose-poke responding 1155 
was rapidly acquired in both, Htr2b+/+ and Htr2b-/- mice (b). No statistical differences between 1156 
genotypes were obtained when data from the acquisition days was analyzed (c). d-g : Lower cocaine 1157 
self-administration in Htr2b-/- mice. A saline solution was presented first until a low and stable 1158 
responding pattern was obtained. Mice were then trained to self-administer cocaine at the dose of 1159 
0.25 mg/kg/infusion during 8 days on a FR1 schedule of reinforcement (d). Htr2b-/- mice show a 1160 
non-significant decrease in the mean intake of cocaine (mg/kg) during the last 3 days of training (e). 1161 
In the dose-response curve for cocaine self-administration, Htr2b-/- mice earned a significantly lower 1162 
number of cocaine infusions at the doses of 0.125 and 0.50 mg/kg/infusion (p<0.05) (f). Each point 1163 
represents the mean of 4 days of responding for each dose. For saline and for the dose of 0.25 1164 
mg/kg/infusion, the point shown represents the mean of the last 4 days of training. Subsequently, a 1165 
progressive ratio procedure was performed in order to test the motivation of mice to work for cocaine 1166 
at the dose of 0.125 mg/kg/infusion (g). The trend toward a lower break point in the progressive ratio 1167 
schedule of reinforcement test did not reach significance (unpaired t-test). h-i : No difference in 1168 
post-cocaine reward system between genotypes. To evaluate the effects of 5-HT2B-receptor 1169 
deletion on post-cocaine reward system, two bottles of water were first available to individually 1170 
caged mice and liquid consumption was monitored during two consecutive days (h). Then, the liquid 1171 
from one of the bottles was replaced with a 2% sucrose solution and liquid intake measurements was 1172 
performed daily during 3 days (i). Total liquid intake, as well as, sucrose preference was evaluated in 1173 
Htr2b+/+ and Htr2b-/- mice. No statistical differences between genotypes were obtained. (n = 18-13, 1174 
unpaired t-test). 1175 








